Andrea Ayers - Convergys CEO

CEO

Ms. Andrea J. Ayers is President, Chief Executive Officer and Directorof the Company. From 2010 2012 She was COO, Convergys Customer Management Group Inc. 2008 2012 President, Convergys Customer Management Group Inc. chosen to serve based upon her industry experience, leadership, and extensive knowledge of our business. With this background, including nearly 30 years of experience with the Company, she is uniquely qualified to understand the Companys challenges and opportunities. since 2012.
Age 53
Tenure 12 years
Phone513 723-7000
Webwww.convergys.com

Convergys Management Efficiency

The company has Return on Asset of 4.71 % which means that on every $100 spent on assets, it made $4.71 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 8.28 %, implying that it generated $8.28 on every 100 dollars invested. Convergys' management efficiency ratios could be used to measure how well Convergys manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 119.9 M in debt with debt to equity (D/E) ratio of 8.8, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Convergys has a current ratio of 2.18, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Convergys until it has trouble settling it off, either with new capital or with free cash flow. So, Convergys' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Convergys sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Convergys to invest in growth at high rates of return. When we think about Convergys' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

David PhippsNextplat Corp
58
Dara KhosrowshahiUber Technologies
54
Convergys Corporation provides customer management services to communications and media, technology, financial services, retail, healthcare, government, travel and hospitality, and other vertical markets worldwide. Convergys Corporation was founded in 1998 and is headquartered in Cincinnati, Ohio. Convergys operates under Business Services classification in USA and is traded on New York Stock Exchange. It employs 110000 people. Convergys (CVG) is traded on New York Stock Exchange in USA and employs 110,000 people.

Management Performance

Convergys Leadership Team

Elected by the shareholders, the Convergys' board of directors comprises two types of representatives: Convergys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Convergys. The board's role is to monitor Convergys' management team and ensure that shareholders' interests are well served. Convergys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Convergys' outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Monahan, Independent Director
Jarrod Pontius, Chief Administrative Officer, General Counsel
Joseph Gibbs, Independent Director
Maria Klyuev, Director, Investor Relations & Marketing
Bo Wang, Independent Non-Executive Director
Marjorie Connelly, COO
Siu Chan, Independent Non-Executive Director
Hua Lu, Executive Director
David Stein, IR Contact Officer
Jeffrey Fox, Non-Executive Chairman of the Board
Michael Wagman, President Managing Director, Director
Richard Devenuti, Independent Director
Isadore Sharp, Independent Director
Ronald Nelson, Lead Independent Director
Joseph Rotman, Independent Director
Richard Wallman, Independent Director
Cormac Twomey, Chief Commercial Officer
John Krediet, Independent Director
Joan Herman, Independent Director
Cheryl Beebe, Director
Gerald Heffernan, Independent Director
Qingxi Wang, Executive Director
Ka Lee, Company Secretary, Non-Executive Director
Andrea Ayers, CEO and President Director and Member of Executive Committee
Weidong Pan, Executive Vice Chairman of the Board
Kin Chak, Executive Director
Andre Valentine, CFO
Huaiyu Wang, Executive Director
Kenneth Rotman, CEO, Managing Director
Jinming Yu, Independent Non-Executive Director
Kathy Juve, Senior Vice President - Global Marketing and Product Development
Chunlei Li, Executive Director
Cuilong Zhang, Executive Director
James Miller, General Counsel, Secretary
John Barrett, Independent Director
Robert Knowling, Director
Chuan Chen, Independent Non-Executive Director
Daniel Cheng, CFO
Joseph Heffernan, Independent Chairman of the Board
John Barnett, Independent Director
Yuk Lo, Independent Non-Executive Director
Michael Bregman, Independent Director
Lionel Schipper, Independent Director
Dongchen Cai, Executive Chairman of the Board, CEO
Jeffrey Parr, Vice Chairman of the Board, Managing Director
Zhenguo Wang, Executive Director

Convergys Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Convergys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Convergys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Convergys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Convergys will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Convergys Stock

If you are still planning to invest in Convergys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Convergys' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities